GLP-1 Drugs Boost Women's Hiring Chances, Study Finds

A new study indicates that unemployed women who take GLP-1 weight loss drugs, such as Ozempic and Wegovy, experience a significant increase in their chances of being hired. The research, published this month and authored by Harvard University economics professor Rebecca Diamond, found that the employment rate for unemployed women rose by 27% after an 18-month period of taking these medications. Diamond's findings suggest that the drugs' impact on visible body weight influences first impressions, which in turn affects hiring outcomes.

Diamond's curiosity about the social and economic effects of GLP-1 drugs was sparked by a friend's personal experience of being treated differently after weight loss. To investigate, she analyzed data from a University of Southern California study involving over 10,000 adults. She compared the outcomes for women who started using GLP-1s with those who were interested but had not yet begun treatment. The study, which is not yet peer-reviewed, highlights that the drugs primarily affect initial perceptions, not solely in professional settings.

The impact of GLP-1 drugs extended to personal relationships as well. Single women who started taking these medications were 29% more likely to enter into marriage or cohabitation within 18 months. However, the study noted a minimal effect on women who were already employed, with no substantial improvements in job mobility or income observed for this group. Diamond posited that existing employment arrangements, where initial impressions were formed long ago and weight is one of many known characteristics, are less susceptible to changes driven by weight loss.

The research underscores the potential for visible physical changes, influenced by pharmacological interventions, to affect societal and economic opportunities. While the study focuses on women, it opens avenues for further investigation into how such interventions might influence perceptions and outcomes across different demographics and professional fields. The findings are based on an analysis of data from a USC study and interviews conducted by Bloomberg and Business Insider.